Literature DB >> 12765335

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

Giuseppina Caligiuri1, Mats Rudling, Véronique Ollivier, Marie-Paule Jacob, Jean-Baptiste Michel, Göran K Hansson, Antonino Nicoletti.   

Abstract

Interleukin (IL)-10 is an anti-inflammatory cytokine that may play a protective role in atherosclerosis. The aim of this study was to assess the effect of IL-10 deficiency in the apolipoprotein E knockout mouse. Apolipoprotein E deficient (E-/-) and IL-10 deficient (-/-) mice were crossed to generate E-/- x IL-10-/- double knockout mice. By 16 wk, cholesterol and triglycerides were similar in double and single knockouts but the lack of IL-10 led to increased low-density lipoprotein cholesterol whereas very-low-density lipoprotein was reduced. In parallel, T-helper 1 responses and lesion size were dramatically increased in double knockout compared with E-/- controls. At 48 wk, matrix metalloproteinases and tissue factor activities were increased in lesions of double-knockout mice. Furthermore, markers of systemic coagulation were increased, and vascular thrombosis in response to i.v. thrombin occurred more frequently in E-/- x IL-10-/- than in E-/- mice. Our findings suggest that IL-10 deficiency plays a deleterious role in atherosclerosis. The early phase of lesion development was increased, and the proteolytic and procoagulant activity was elevated in advanced lesions. These data show that IL-10 may reduce atherogenesis and improve the stability of plaques.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765335      PMCID: PMC1430379     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  52 in total

1.  In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice.

Authors:  E Laurat; B Poirier; E Tupin; G Caligiuri; G K Hansson; J Bariéty; A Nicoletti
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Interleukin-10 blocks atherosclerotic events in vitro and in vivo.

Authors:  L J Pinderski Oslund; C C Hedrick; T Olvera; A Hagenbaugh; M Territo; J A Berliner; A I Fyfe
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

3.  Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice.

Authors:  S C Whitman; P Ravisankar; H Elam; A Daugherty
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse.

Authors:  J L Johnson; C L Jackson
Journal:  Atherosclerosis       Date:  2001-02-01       Impact factor: 5.162

Review 5.  Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

Authors:  M M Véniant; S Withycombe; S G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

6.  Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse.

Authors:  M E Rosenfeld; P Polinsky; R Virmani; K Kauser; G Rubanyi; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

7.  Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo.

Authors:  D Verthelyi; D M Klinman
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

8.  Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol.

Authors:  H Gullberg; M Rudling; D Forrest; B Angelin; B Vennström
Journal:  Mol Endocrinol       Date:  2000-11

9.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.

Authors:  G Liuzzo; J J Goronzy; H Yang; S L Kopecky; D R Holmes; R L Frye; C M Weyand
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

10.  Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells.

Authors:  V Arnman; S Stemme; L Rymo; B Risberg
Journal:  Thromb Res       Date:  1995-03-01       Impact factor: 3.944

View more
  121 in total

1.  Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Nekeithia S Wade; Curtis L Gabriel; John J Kastelein; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

2.  Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.

Authors:  Takayuki Kimura; Kevin Tse; Sara McArdle; Teresa Gerhardt; Jacqueline Miller; Zbigniew Mikulski; John Sidney; Alessandro Sette; Dennis Wolf; Klaus Ley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-13       Impact factor: 4.733

Review 3.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

4.  Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.

Authors:  Qun Li; Weihong Sun; Xinwen Wang; Ke Zhang; Wenda Xi; Pingjin Gao
Journal:  Stem Cells Transl Med       Date:  2015-09-23       Impact factor: 6.940

5.  IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Authors:  Poonam Kothari; Roberto Pestana; Rim Mesraoua; Rim Elchaki; K M Faisal Khan; Andrew J Dannenberg; Domenick J Falcone
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

Review 6.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 7.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 8.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

Review 9.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

10.  Systemic inflammation in non-obese children with obstructive sleep apnea.

Authors:  David Gozal; Laura D Serpero; Oscar Sans Capdevila; Leila Kheirandish-Gozal
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.